J Natl Compr Canc Netw
Dr. Erin M. Bertino, MD
- Medicare services, 2024
- 2,228
- Medicare patients, 2024
- 244
- Part D claims, 2024
- 748
- Publications
- 41
- Clinical trials
- 10
- Practice address
- 300 Polaris Pkwy, Westerville, OH 43082
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Polaris Surgery Center - HOPD
Acute Care Hospital outpatient department · Westerville, Ohio
Find Dr. Bertino's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Erin M. Bertino is a hematologist and oncologist in Westerville, Ohio
Dr. Bertino practices at Polaris Surgery Center - HOPD in Westerville, Ohio.
Dr. Bertino's NPI, 1043355688, was assigned on February 21, 2007. Dr. Bertino graduated from Northeastern Ohio University College of Medicine in 2004. Dr. Bertino holds Ohio license 35.088851.
- NPI
- 1043355688NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7012015381
- NPI enumeration date
- February 21, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 48
- Medical school graduation
- 2004
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Erin M. Bertino practices at Polaris Surgery Center - HOPD in Westerville, Ohio
Dr. Bertino's primary practice is Polaris Surgery Center - HOPD, at 300 Polaris Pkwy, Westerville, OH 43082.
- Polaris Surgery Center - HOPD300 Polaris Pkwy, Westerville, OH 43082
Source: Dmand AI Affiliation Data
Dr. Erin M. Bertino is affiliated with 10 sites of care and 4 medical groups
Dr. Bertino's primary practice is Polaris Surgery Center - HOPD in Westerville, Ohio. Dr. Bertino is also affiliated with OhioHealth Riverside Methodist Hospital. The medical group on file is OhioHealth Physician Group. Dmand AI also links Dr. Bertino to 3 more hospitals, 3 group practices and clinics, 3 medical groups and 2 ambulatory surgery centers, each named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Erin M. Bertino's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bertino practices, 10 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Polaris Surgery Center - HOPD | Available with a free account |
| +9 more sites and 3 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Erin M. Bertino is one of 460 hematologists and oncologists in Ohio
Hematology and oncology is Dr. Bertino's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bertino is licensed in Ohio.
Specialties and state licenses
- Hematology and oncology, OhioPrimary
Hematologists and oncologists near Dr. Bertino
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Erin M. Bertino billed Medicare for 2,228 services in 2024
CMS data shows 2,228 Medicare services from Dr. Bertino across 21 procedure codes in 2024, for 244 Medicare patients. Medicare paid $80,441 for them.
Dr. Bertino's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 2702024: 1,104309%
- Other services
- 2023: 02024: 407
- Office and hospital visits
- 2023: 3292024: 36110%
- Tests and treatments
- 2023: 1242024: 356187%
Where Dr. Bertino's Medicare services took place, 2024
- In an office2,18398%
- In a facility452%
Dr. Bertino compared with the Ohio median for hematologists and oncologists, 2024
- Dr. Bertino
- Ohio median
- Medicare services
- 2,228vs 6263.6 times
- Medicare patients
- 244vs 234Close to median
- Part D claims
- 460vs 478Close to median
Medians across 452 hematologists and oncologists in Ohio with Dmand AI profiles that report each measure.
Dr. Bertino's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Bertino?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Bertino and other hematologists and oncologists in Ohio.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Erin M. Bertino treated 244 Medicare patients in 2024, average age 74
CMS counts 244 Medicare patients who saw Dr. Bertino in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Bertino's median patient age at 68, with 65% women.
Dr. Bertino's Medicare patients by age, 2024
Dr. Bertino's Medicare patients by sex, 2024
- Women14258%
- Men10242%
Chronic conditions among Dr. Bertino's Medicare patients, 2024
- High blood pressure75%
- High cholesterol73%
- Arthritis48%
- Cancer47%
- Chronic kidney disease32%
- Diabetes32%
- Ischemic heart disease32%
- Anxiety31%
Share of Medicare patients with each condition. A patient can have several.
Dr. Bertino's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women65%
- Men34%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Erin M. Bertino wrote 748 Medicare Part D claims in 2024
In 2024, Dr. Bertino wrote 748 Medicare Part D claims for 132 patients. 87% of them were for generic drugs. CMS names the drug for 460 of them, across 17 drugs with 11 or more claims each, at $358,974 in total drug cost. In 2023, CMS named 462 claims across 17 drugs.
Dr. Bertino's Part D claims by kind of drug, 2024
- Generic649 claims87%
- Brand-name and other99 claims13%
Dr. Bertino's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Bertino's Part D claims, 2024
- Opioids9%64 of 748 claims
- Antibiotics7%53 of 748 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 4622024: 460No change
Drugs named by CMS: 17 in 2024, 17 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Erin M. Bertino offers telehealth to Medicare patients
Dr. Bertino accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bertino as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Erin M. Bertino has 41 publications on record
Dmand AI links 41 papers to Dr. Bertino, published from 2011 to 2024. 2017 was the busiest year, with 5. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Antineoplastic Agents. Dr. Bertino has published most often in Lung Cancer. Dr. Bertino's most frequent co-authors are Gregory A. Otterson, MD, David Paul Carbone, MD, PhD and Peter Gary Shields, MD.
Dr. Bertino's papers by year, 2015 to 2024
Topics Dr. Bertino writes about most
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
- Palliative Care
- Immune Checkpoint Inhibitors
- Immunotherapy
- Protein Kinase Inhibitors
Dr. Bertino's most frequent co-authors
- Gregory A. Otterson, MD21 shared papers
- David Paul Carbone, MD, PhD13 shared papers
- Peter Gary Shields, MD10 shared papers
Recent publications by Dr. Bertino
Int J Radiat Oncol Biol Phys
Cancer Immunol Immunother
See who Dr. Bertino researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Bertino works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Erin M. Bertino has worked on 10 clinical trials
Dmand AI links Dr. Bertino to 10 clinical trials, 5 of them phase 2 studies. 8 are still active or recruiting. Conditions studied include Lung Neoplasms, Thoracic Neoplasms and Adenocarcinoma of Lung. National Cancer Institute (NCI) sponsors the most, 5.
Clinical trials with Dr. Bertino by phase
- 1Phase 1: 1 trial
- 5Phase 2: 5 trials
- 1Phase 2/3: 1 trial
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Bertino's trials
- Lung Neoplasms
- Thoracic Neoplasms
- Adenocarcinoma of Lung
- Rectal Diseases
- Thyroid Neoplasms
Investigators on the most trials with Dr. Bertino
- Ryan D. Gentzler, MD5 shared trials
- Lyudmila A. Bazhenova, MD4 shared trials
- Christina Seung Baik, MD3 shared trials
Recent clinical trials with Dr. Bertino
Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy (opens in a new tab)
Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Erin M. Bertino received $80,310 in industry payments from 2017 to 2025
CMS Open Payments shows 66 general payments to Dr. Bertino from 13 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 57% of the total. Pfizer Inc. paid the most, $45,321.
General payments to Dr. Bertino by program year, 2017 to 2025
General payments to Dr. Bertino by kind, 2017 to 2025
- Speaker and faculty fees$45,51957%
- Consulting fees$26,39633%
- Travel and lodging$6,4588%
- Food and beverage$1,8842%
- Education$530%
Companies that paid Dr. Bertino the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Erin M. Bertino graduated from Northeastern Ohio University College of Medicine
Dr. Bertino graduated from Northeastern Ohio University College of Medicine in 2004.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Erin M. Bertino's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Erin M. Bertino
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Erin M. Bertino's NPI number?
Dr. Erin M. Bertino's NPI number is 1043355688. It was assigned on February 21, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Erin M. Bertino?
Dr. Erin M. Bertino is a hematologist and oncologist in Westerville, Ohio. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Erin M. Bertino practice?
Dr. Bertino practices at 300 Polaris Pkwy, Westerville, OH 43082. Dr. Bertino's primary practice is Polaris Surgery Center - HOPD in Westerville, Ohio. Dmand AI also links Dr. Bertino to 3 hospitals, 3 group practices and clinics, 3 medical groups and 2 ambulatory surgery centers.
What is Dr. Erin M. Bertino's medical license number?
Dr. Bertino holds Ohio license 35.088851.
Which hospitals is Dr. Erin M. Bertino affiliated with?
Dr. Bertino is affiliated with OhioHealth Riverside Methodist Hospital. Dmand AI links Dr. Bertino to 3 more hospitals.
What medical group is Dr. Erin M. Bertino part of?
Dr. Bertino is linked to OhioHealth Physician Group. Dmand AI links Dr. Bertino to 3 more medical groups.
Does Dr. Erin M. Bertino accept Medicare?
Yes. CMS data shows Dr. Bertino billed Medicare for 2,228 services in 2024, and Dr. Bertino accepts Medicare assignment.
Does Dr. Erin M. Bertino offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Bertino as offering telehealth services.
How many Medicare patients does Dr. Erin M. Bertino see?
CMS counts 244 Medicare patients who saw Dr. Bertino in 2024, with an average age of 74.
What services does Dr. Erin M. Bertino bill to Medicare?
In 2024, Dr. Bertino's most billed Medicare services were injected or infused drug (J1100), injected or infused drug (J2469) and medicare temporary code (Q5111).
Show 6 more questionsShow fewer questions
Where did Dr. Erin M. Bertino go to medical school?
Dr. Bertino graduated from Northeastern Ohio University College of Medicine in 2004.
What drugs does Dr. Erin M. Bertino prescribe most?
In 2024 Medicare Part D data, Dr. Bertino's most prescribed drugs by claims were Anastrozole, Letrozole and Dexamethasone.
Has Dr. Erin M. Bertino received payments from drug or device companies?
CMS Open Payments shows $80,310 in general payments to Dr. Bertino from 13 companies from 2017 to 2025. The largest total came from Pfizer Inc.
How long has Dr. Erin M. Bertino been practicing?
Dr. Bertino graduated from medical school in 2004, 22 years ago.
Does Dr. Erin M. Bertino do research?
Dmand AI links 41 publications to Dr. Bertino, published from 2011 to 2024. Dr. Bertino has worked on 10 clinical trials.
Who does Dr. Erin M. Bertino publish with?
Dr. Bertino's most frequent co-authors are Gregory A. Otterson, MD (21 shared papers), David Paul Carbone, MD, PhD (13 shared papers) and Peter Gary Shields, MD (10 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Ohio by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card